Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Shulman

Showing results (361-370 of 422) with videos related to

Pageof 43
Sort By:
Archives of Otolaryngology (Chicago, Ill. : 1960)|April 1, 1983
Thyroid tumor imagingA M Noyek, N D Greyson, M I Steinhardt, et al.
American Journal of Clinical Pathology|September 21, 2014
Diagnosis of cancer in rural Rwanda: early outcomes of a phased approach to implement anatomic pathology services in resource-limited settingsTharcisse Mpunga, Neo Tapela, Bethany L Hedt-Gauthier, et al.
Preparative Biochemistry|January 1, 1975
Structural and compositional changes attending the ultracentrifugation of very low density lipoproteinsP N Herbert, T M Forte, R S Shulman, et al.
American Heart Journal|April 1, 1987
Echocardiographic diagnosis of an infected myxoma in an atypical locationE W Bough, E E Johnson, S I Zacks, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|October 24, 2002
Subtle decreases in stavudine phenotypic susceptibility predict poor virologic response to stavudine monotherapy in zidovudine-experienced patientsNancy S Shulman, Michael D Hughes, Mark A Winters, et al.
Journal of Immunology (Baltimore, Md. : 1950)|December 1, 1983
Lipid bodies: cytoplasmic organelles important to arachidonate metabolism in macrophages and mast cellsA M Dvorak, H F Dvorak, S P Peters, et al.
Antiviral Therapy|February 6, 2004
Nucleoside and nucleotide analogue reverse transcriptase inhibitors: a clinical review of antiretroviral resistanceJoel E Gallant, Peter Z Gerondelis, Mark A Wainberg, et al.
European Journal of Gastroenterology & Hepatology|May 16, 2018
Ombitasvir/paritaprevir/ritonavir+dasabuvir+ribavirin for chronic hepatitis C virus genotype 1b-infected cirrhotics (TURQUOISE-IV)Vasily Isakov, Dzmitry Paduta, Rolando M Viani, et al.
The Journal of Infectious Diseases|March 23, 2017
TURQUOISE-I Part 1b: Ombitasvir/Paritaprevir/Ritonavir and Dasabuvir with Ribavirin for Hepatitis C Virus Infection in HIV-1 Coinfected Patients on DarunavirDavid Wyles, Michael Saag, Rolando M Viani, et al.
Pediatric Blood & Cancer|September 16, 2023
Phase 1 study of cabozantinib in combination with topotecan-cyclophosphamide for patients with relapsed Ewing sarcoma or osteosarcomaKevin Campbell, Andrew Posner, Nan Chen, et al.
Pageof 43

Showing results (361-370 of 422) with videos related to

Sort By:
Pageof 43
Archives of Otolaryngology (Chicago, Ill. : 1960)|April 1, 1983
Thyroid tumor imagingA M Noyek, N D Greyson, M I Steinhardt, et al.
American Journal of Clinical Pathology|September 21, 2014
Diagnosis of cancer in rural Rwanda: early outcomes of a phased approach to implement anatomic pathology services in resource-limited settingsTharcisse Mpunga, Neo Tapela, Bethany L Hedt-Gauthier, et al.
Preparative Biochemistry|January 1, 1975
Structural and compositional changes attending the ultracentrifugation of very low density lipoproteinsP N Herbert, T M Forte, R S Shulman, et al.
American Heart Journal|April 1, 1987
Echocardiographic diagnosis of an infected myxoma in an atypical locationE W Bough, E E Johnson, S I Zacks, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|October 24, 2002
Subtle decreases in stavudine phenotypic susceptibility predict poor virologic response to stavudine monotherapy in zidovudine-experienced patientsNancy S Shulman, Michael D Hughes, Mark A Winters, et al.
Journal of Immunology (Baltimore, Md. : 1950)|December 1, 1983
Lipid bodies: cytoplasmic organelles important to arachidonate metabolism in macrophages and mast cellsA M Dvorak, H F Dvorak, S P Peters, et al.
Antiviral Therapy|February 6, 2004
Nucleoside and nucleotide analogue reverse transcriptase inhibitors: a clinical review of antiretroviral resistanceJoel E Gallant, Peter Z Gerondelis, Mark A Wainberg, et al.
European Journal of Gastroenterology & Hepatology|May 16, 2018
Ombitasvir/paritaprevir/ritonavir+dasabuvir+ribavirin for chronic hepatitis C virus genotype 1b-infected cirrhotics (TURQUOISE-IV)Vasily Isakov, Dzmitry Paduta, Rolando M Viani, et al.
The Journal of Infectious Diseases|March 23, 2017
TURQUOISE-I Part 1b: Ombitasvir/Paritaprevir/Ritonavir and Dasabuvir with Ribavirin for Hepatitis C Virus Infection in HIV-1 Coinfected Patients on DarunavirDavid Wyles, Michael Saag, Rolando M Viani, et al.
Pediatric Blood & Cancer|September 16, 2023
Phase 1 study of cabozantinib in combination with topotecan-cyclophosphamide for patients with relapsed Ewing sarcoma or osteosarcomaKevin Campbell, Andrew Posner, Nan Chen, et al.
Pageof 43